BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2192103)

  • 21. [KMO1].
    Kamigaki T; Kuroda Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():691-3. PubMed ID: 16149613
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (1)].
    Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1901-6. PubMed ID: 2439020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumor markers in the diagnosis of tumors of the liver and biliary tract].
    Marecek Z
    Vnitr Lek; 1997 Mar; 43(3):167-70. PubMed ID: 9221578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 levels in the evaluation of malignant/benign pancreaticobiliary disease: hope or hype?
    Gessner CE; Baillie J
    Am J Gastroenterol; 1996 Feb; 91(2):401-2. PubMed ID: 8607524
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ultrasonic percutaneous imaging of neoplasms of liver, biliary tract and pancreas].
    Tsuchiya Y; Nakano T; Tsunetomi S; Shinagawa T; Ukazi H; Unozawa T; Iino Y; Watanabe J; Morita M; Kimura K; Saisyo H; Ohto M; Ebara M; Karasawa E; Saotome N
    Nihon Rinsho; 1982; 40(1):102-8. PubMed ID: 6283196
    [No Abstract]   [Full Text] [Related]  

  • 26. [KMO1].
    Kamigaki T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():736-8. PubMed ID: 20960860
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypsinogen activation peptide (TAP) expression in gallbladder bile identifies bilio-pancreatic carcinoma.
    Brockmann JG; Hernandez CA; Emparan C; Wolters H; Haier J; Dietl KH; Senninger NJ
    Anticancer Res; 2003; 23(2A):819-25. PubMed ID: 12820306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasms].
    Guidi L; Bartoloni C; Pellicanò P; Cappelli A; Cursi F; Pili R; Tricerri A; Patriarca F; Gambassi G
    Clin Ter; 1991 Mar; 136(6):367-73. PubMed ID: 1828201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytological diagnosis of neoplasms of the duodenal, hepatic, pancreatic and biliary system].
    Shida S; Matsuzawa Y; Muto K; Takada E
    Rinsho Byori; 1980; Suppl():165-76. PubMed ID: 7411956
    [No Abstract]   [Full Text] [Related]  

  • 31. [Early diagnostic system of minute hepatocellular carcinoma, and neoplasms of biliary tract and pancreas].
    Okuda K; Tsuchiya Y; Saisho H
    Nihon Rinsho; 1982; 40(1):146-50. PubMed ID: 6283199
    [No Abstract]   [Full Text] [Related]  

  • 32. [1995 gastroenterology update--II].
    Layer P; Brambs HJ; Ell C; Fischbach W; Fleig WE; Schölmerich J; Zirngibl H
    Med Klin (Munich); 1996 Apr; 91 Suppl 1():81-8. PubMed ID: 8657091
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytodiagnosis of neoplasms of the liver, biliary tract and pancreas].
    Shida S; Muto K; Takada E; Ikeguchi S; Matsuzawa Y; Yokota K
    Nihon Rinsho; 1982; 40(1):135-45. PubMed ID: 7087199
    [No Abstract]   [Full Text] [Related]  

  • 34. Development and evaluation of monoclonal antibody-based immunoassays: breast carcinoma-associated mucins as tumor markers.
    Brown JP; Linsley PS; Horn D
    Immunol Ser; 1990; 53():69-82. PubMed ID: 1713071
    [No Abstract]   [Full Text] [Related]  

  • 35. [Liver, pancreas, biliary tract cancer].
    Miyazaki M
    Gan To Kagaku Ryoho; 2013 Oct; 40(10):1295-6. PubMed ID: 24312978
    [No Abstract]   [Full Text] [Related]  

  • 36. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
    Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Liver, pancreas, biliary tract cancer-2011 update].
    Arii S
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1599. PubMed ID: 22081855
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urine diacetylspermine as a novel tumor marker].
    Yamaguchi K; Kaku T; Enjoji M; Kato M; Anai M; Kawakita M; Hamasaki N; Tanaka M
    Rinsho Byori; 2005 Feb; 53(2):130-5. PubMed ID: 15796046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The incidence, clinical and biologic diagnosis, and prognosis of cancer of the exocrine pancreas and biliary tract].
    Gainant A; Cubertafond P
    Rev Prat; 1989 Oct; 39(22):1933-7. PubMed ID: 2814274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.